Gene: EIF4G2
Official Full Name: eukaryotic translation initiation factor 4 gamma 2provided by HGNC
Gene Summary: Translation initiation is mediated by specific recognition of the cap structure by eukaryotic translation initiation factor 4F (eIF4F), which is a cap binding protein complex that consists of three subunits: eIF4A, eIF4E and eIF4G. The protein encoded by this gene shares similarity with the C-terminal region of eIF4G that contains the binding sites for eIF4A and eIF3; eIF4G, in addition, contains a binding site for eIF4E at the N-terminus. Unlike eIF4G, which supports cap-dependent and independent translation, this gene product functions as a general repressor of translation by forming translationally inactive complexes. In vitro and in vivo studies indicate that translation of this mRNA initiates exclusively at a non-AUG (GUG) codon. Alternatively spliced transcript variants encoding different isoforms of this gene have been described. [provided by RefSeq, Jul 2008]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO06802 | EIF4G2 Knockout cell line (HeLa) | Human | EIF4G2 | 1:3~1:6 | Negative | Online Inquiry |
KO06803 | EIF4G2 Knockout cell line (HCT 116) | Human | EIF4G2 | 1:2~1:4 | Negative | Online Inquiry |
KO06804 | EIF4G2 Knockout cell line (HEK293) | Human | EIF4G2 | 1:3~1:6 | Negative | Online Inquiry |
EIF4G2 Gene Knockout Cell Lines are specialized cellular models designed to facilitate the study of gene function, particularly focusing on the eukaryotic initiation factor 4G2 (EIF4G2), a key regulatory protein involved in mRNA translation and cellular stress responses. These cell lines are engineered through precise CRISPR/Cas9 technology to disrupt the EIF4G2 gene, effectively enabling researchers to investigate the downstream effects of its loss and the implications for protein synthesis mechanisms in eukaryotic cells.
The primary function of EIF4G2 is to serve as a scaffold in the assembly of the translation initiation complex, influencing the recruitment of ribosomes to mRNA. By utilizing these knockout models, researchers can directly observe alterations in translational efficiency, identify compensatory mechanisms, and delineate the role of EIF4G2 in various cellular processes, including growth, differentiation, and apoptosis. This knowledge is crucial, as dysregulation of translation is implicated in numerous diseases, including cancer and neurodegenerative disorders.
In research and clinical settings, the ability to use EIF4G2 Gene Knockout Cell Lines streamlines experimental workflows, enabling a more rapid assessment of gene function and pathway elucidation compared to conventional methods. Their specificity and reliability provide significant advantages over pharmacological inhibitors or wild-type strains, which may not accurately reflect genetic influences on translation.
For researchers and clinicians seeking to uncover the complexities of gene interactions and their implications for therapeutic strategies, our EIF4G2 knockout lines represent an invaluable resource. They not only contribute to fundamental biological understanding but also pave the way for the development of targeted interventions in translation-related diseases.
Our company prides itself on its expertise in generating cutting-edge biological research tools, ensuring the highest quality and reproducibility in all our products. By choosing our EIF4G2 Gene Knockout Cell Lines, users gain access to an innovative solution aimed at advancing their research and clinical applications in genetic and translational biology.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.